Evidence map›Paper›PMID 33066645›Full record

ArticleLife (Basel, Switzerland)2020

Non-Criteria Antiphospholipid Antibodies: Risk Factors for Endothelial Dysfunction in Women with Pre-Eclampsia.

Lara Belmar Vega, Gema Fernández Fresnedo, Juan Irure Ventura, Victoria Orallo Toural, Milagros Heras Vicario, Juan Carlos Ruiz San Millán, Emilio Rodrigo, Marcos López Hoyos

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lara Belmar VegaNephrology Service, University Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Gema Fernández FresnedoNephrology Service, University Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Juan Irure VenturaImmunology Service, University Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Victoria Orallo TouralObstetrics and Gynecology Service, University Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Milagros Heras VicarioNephrology Service, University Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Juan Carlos Ruiz San MillánNephrology Service, University Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Emilio RodrigoNephrology Service, University Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Marcos López HoyosImmunology Service, University Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Marqués de Valdecilla University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between unconventional antiphospholipid antibodies and pre-eclampsia in patients without thrombotic manifestations and its relationship with endothelial dysfunction after delivery has been studied poorly. We included 157 pregnant women, 122 of them having developed pre-eclampsia (56 non-severe and 66 severe). The determination of classical and unconventional, as well as pulse wave velocity and ankle-brachial index were performed at three months after delivery. The prevalence of unconventional antiphospholipid antibodies was 22.9% and 54.9% in patients included in control and pre-eclampsia groups, respectively (

Indexed as

ankle-brachial indexantiphosphatidylserine/prothrombin antibodiesantiphospholipid antibodiespre-eclampsiapulse wave velocity

Identifiers

PMID33066645
PMCPMC7650548
OpenAlexW3093214363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.